StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report issued on Tuesday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
Check Out Our Latest Stock Analysis on Veradigm
Veradigm Price Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Want to Profit on the Downtrend? Downtrends, Explained.
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Top Biotech Stocks: Exploring Innovation Opportunities
- Top 3 Beverage Stocks Pouring Out Profits
- How to Plot Fibonacci Price Inflection Levels
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
